CBU
INSM icon

CIBC Bancorp USA’s Insmed INSM Stock Holding History

CIBC Bancorp USA’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$955K Sell
9,068
-1,938
-18% -$235K ﹤0.01% 1114
2026
Q1 		$1.8M Buy
+11,006
New +$1.69M ﹤0.01% 927

Other funds holding INSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CIBC Bancorp USA's INSM Position: Q2 2026 in Review

CIBC Bancorp USA reduced its Insmed (INSM) stake by 18% in Q2 2026, selling an estimated $235K and leaving 9,068 shares worth $955K. The position accounts for ﹤0.01% of the portfolio, ranked #1114.

CIBC Bancorp USA first reported a position in INSM in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.8M in Q1 2026. 609 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • CIBC Bancorp USA held 9,068 shares of Insmed worth $955K as of Q2 2026.
  • CIBC Bancorp USA sold 1,938 Insmed shares in Q2 2026, an estimated $235K.
  • Insmed made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1114 holding.
  • CIBC Bancorp USA first reported a position in Insmed in Q1 2026 and has held it in 2 quarters since.
  • CIBC Bancorp USA's Insmed position peaked at $1.8M in Q1 2026.
  • 609 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.